uestion 8 of 14 > |side-by-Side Attempt 3 Subjects with preexisting cardiovascular symptoms who State hypotheses and then find the test statistic. Give your were receiving subutramine, an appetite suppressant, were answer to two decimal places. found to be at increased risk of cardiovascular events while taking the drug. The study included 9645 overweight or obese subjects with preexisting cardiovascular disease and/or type 2 diabetes. The subjects were randomly 2.1238 assigned to subutramine (4798 subjects) or a placebo (4847 Z = subjects) in a double-blind fashion. The primary outcome Incorrect measured was the occurrence of any of the following events: nonfatal myocardial infarction or stroke, Use either software or the bottom row of Table C for the resuscitation after cardiac arrest, or cardiovascular death. P-value. Give your answer to four decimal places. The primary outcome was observed in 552 subjects in the subutramine group and 491 subjects in the placebo group. Do the data give good reason to think that there is a difference between the proportions of treatment and placebo P-value: 0.01684 subjects who experienced the primary outcome? (Note that sibutramine has not been available in the United States since the end of 2010 due to its manufacturer's concerns over increased risk of heart attack or stroke, State your conclusion. although at the present time, it can still be purchased in other countries.) There is no evidence that the proportion of subjects